MENU
OMER
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Omeros (OMER) Ownership - Who owns Omeros?
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
220.89M
P/E Ratio
N/A
Total Cash
123.16M
Projected Growth
N/A
Total Debt
209.47M
Revenue
N/A
Risk (Beta)
3.91
Dividend Yield
N/A
Total Cash/Share
2.10
Total Debt/Equity
618.04
Revenue/Share
null USD as % of share price
Fundamentals
OMER
Capitalization
221M
P/E Ratio
N/A
Risk (Beta)
3.91
Dividend Yield
N/A
Total Cash
123M
Total Cash/Share
2.10
Total Debt
209M
Total Debt/Equity
618.04
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-154.17M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
579K
Current Ratio
2.96
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-155.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.36
Shares Held By Institutions
330M
Shares Outstanding - Current
58.6M
Total Liabilities
468M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-61.842
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com